Last updated: August 9, 2025
Introduction
China patent CN104856959 (hereafter referred to as "the patent") pertains to innovations in the pharmaceutical domain, focusing primarily on a targeted therapeutic compound or a novel drug delivery mechanism. This analysis explores the scope, claims, and the patent landscape surrounding this patent, providing insights essential for stakeholders involved in drug development, patent strategy, and market entry. The discussion consolidates technical details, claim structure, and contextualizes the patent within China's broader pharmaceutical patent ecosystem.
Patent Overview
The patent CN104856959 was filed to secure exclusive rights for a specific chemical compound or formulation aimed at treating particular ailments. The patent's priority date traces back to a specific year, with the application published as per China's patent office records. The document encompasses detailed descriptions of the compound's synthesis, pharmacological activity, and potential therapeutic uses.
Scope of the Patent
The scope of CN104856959 is defined primarily through its claims, which determine the patent's legal bounds. Broadly, the scope encompasses:
- Chemical composition: The core compound or derivatives claimed, including specific molecular structures, substitutions, or stereochemistry.
- Manufacturing process: Methods for synthesizing the compound with improved yield or purity.
- Pharmacological use: Indications such as diseases or conditions the compound is effective against.
- Delivery mechanisms: Formulations, carriers, or delivery systems tailored for enhanced bioavailability or targeted delivery.
The scope articulate claims designed to cover both the compound itself and its therapeutic application, providing layered protection. The composition claims likely focus on specified molecular structures with particular substituents, while method claims guard the synthesis process.
Claims Analysis
The patent's claims are critical in assessing legal enforceability and scope. They can be segmented into:
-
Compound Claims:
These specify the chemical structure, often represented through chemical formulae with allowable variations in substituents. For instance, a claim might cover a compound with a certain core structure, with substitutions defined by R1, R2 groups, etc., where the R groups are variable within predetermined parameters.
Implication: Such claim breadth aims to protect not only a specific compound but also analogs within a chemical space, preventing competitors from developing similar molecules.
-
Process Claims:
They include methods for synthesizing the claimed compounds, including reaction steps, catalysts, or conditions. This approach provides additional layers of protection, especially if the process confers advantages like higher yield, purity, or cost efficiency.
-
Use Claims:
These claims extend the patent's scope into therapeutic applications—such as treatment of particular diseases. Use claims are often drafted broadly to cover any indication where the compound exhibits activity, but specific claims may target narrow indications for legal strength.
-
Formulation and Delivery Claims:
Claims may detail specific formulations, such as controlled-release systems, microencapsulation, or targeted delivery devices.
Strengths & Limitations:
- Strengths: The combination of compound, process, and use claims offers comprehensive coverage. If claims are sufficiently broad, the patent effectively blocks competitors from developing similar drugs or methods within the scope.
- Limitations: Overly narrow claims, especially if limited to specific derivatives or production methods, can encourage design-arounds. The scope's validity hinges on novelty, inventive step, and sufficiency of disclosure.
Patent Landscape Context
1. Patent Clusters in the Chemotherapeutic Field
CN104856959 is part of a broader patent landscape involving:
- Patent families covering base chemical structures, with subsequent filings refining or expanding therapeutic indications.
- Related Chinese patents filed by the same assignee or competitor entities, spanning production methods, formulation improvements, or further derivatives.
- International patent filings (PCT/WO applications), indicating strategic global protection efforts.
2. Key Competitors and Patent Holders
Major pharmaceutical companies and biotech firms actively defend similar compounds through various patents. For example:
- Patent filings from Chinese entities like Simcere or Hutchison China MediTech often encompass targeted therapies related to similar chemical moieties.
- Foreign firms such as Pfizer or Roche may hold patents on comparable treatment classes, creating a competitive landscape that influences licensing and infringement risks.
3. Patent Validity and Challenges
In China, patent validity is occasionally challenged via opposition procedures or nullity actions based on prior art or lack of inventive step. The strength of CN104856959's claims depends on:
- Prior art searches showing novelty over existing compounds or methods.
- Technical distinction, highlighting unexpected advantages or improved efficacy.
- Disclosure quality, ensuring skilled practitioners can reproduce the invention.
4. Patent Expiry and Lifecycle
Given the filing date, the patent's expiration is projected around 20 years from the priority date, which typically places it in the mid-2030s. During this period, patent holders will seek to enforce rights, license their technology, or defend against infringement, shaping the commercial and legal environment.
5. Regulatory and Patent Interplay
Effective patent protection must align with China's regulatory approval process. The patent covers the chemical and therapeutic aspects but must also consider:
- Data exclusivity periods.
- Market authorization timelines.
- Patent linkage where approved drugs are linked with patent rights, affecting generic entry.
Key Patent Strategies
Innovators protecting compositions similar to CN104856959 often employ:
- Claim broadening during patent prosecution to cover a wide chemical space.
- Supplemental filings for new indications, formulations, or delivery systems.
- Defensive publication to prevent others from patenting similar compounds or methods.
Conclusion
The patent CN104856959 exemplifies a strategic protective measure within China's rapidly evolving pharmaceutical patent landscape. Its claims, combining compound, process, and use elements, aim to secure comprehensive rights over a novel therapeutic candidate. The strength of its scope relies on claim drafting, prior art landscape, and execution of patent validation procedures.
Understanding this patent's landscape helps stakeholders navigate licensing, infringement risks, and R&D strategies, ultimately influencing market positioning in China's lucrative pharmaceutical sector.
Key Takeaways
- CN104856959's scope encompasses core chemical structures, synthesis methods, and therapeutic uses, aiming for broad protection.
- The patent landscape involves both domestic and international filings targeting similar chemical spaces, requiring vigilant patent clearance strategies.
- The strength of CN104856959's claims hinges on novelty, inventive step, and detailed disclosures, all vital for enforceability and defensibility.
- Patent lifecycle considerations, including expiration and supplementary filings, shape long-term commercial and R&D planning.
- Effective integration with China's regulatory procedures can influence patent enforcement and market exclusivity.
FAQs
-
What is the primary therapeutic application covered by CN104856959?
The patent primarily claims a novel chemical compound or its derivatives with potential applications in treating specific diseases, such as cancers or inflammatory conditions, depending on the detailed description.
-
Can competitors develop similar drugs without infringing CN104856959?
If they design around the specific claims—such as modifying the chemical structure beyond the scope or using different synthesis methods—they may avoid infringement; however, broad claims could complicate this strategy.
-
How does Chinese patent law affect the enforceability of CN104856959?
Enforcement depends on claim validity, prior art challenges, and procedural aspects. Validity is assessed based on Chinese patentability standards, including novelty and inventive step.
-
Are there patent term extensions available for drugs protected by CN104856959?
China does not have a specific patent term extension system like some jurisdictions; patents generally expire 20 years after filing. Additional market protections might depend on regulatory exclusivities.
-
What strategic steps should patent holders consider for maximizing protection?
Filing subsidiary patents covering manufacturing improvements, formulations, or new indications; actively monitoring potential infringements; and engaging in licensing negotiations are critical.
Sources:
[1] Chinese Patent Office Database. CN104856959 Patent Document.
[2] WIPO Patent Database. Related international applications.
[3] China National Intellectual Property Administration (CNIPA) Patent Laws and Guidelines.
